We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Victor Fung

Victor S. C. Fung PhD, FRACP

Director, Movement Disorders Unit & Head, Department of Neurology, Westmead Hospital; Conjoint Associate Professor, University of Sydney, Sydney, Australia

Dr. Victor Fung is Conjoint Associate Professor at Sydney Medical School, The University of Sydney, and Head of Department and Director of the Movement Disorders Unit, Department of Neurology, Westmead Hospital in Sydney, Australia. He is Co-Chair of the Publications and Communications Oversight Committee of the International Parkinson and Movement Disorder Society (IPMDS) and has been a past Treasurer and past Chair of its Congress Scientific Program Committee. He is Chair of the Asia Pacific Affairs Committee of the Australian and New Zealand Association of Neurologists, and is a past-President of the Movement Disorder Society of Australia and New Zealand (MDSANZ). He was the founding Chairperson of the MDSANZ Clinical Research and Trials Group. He is a member of the Parkinson's Australia, Parkinson's NSW and Dystonia Network Australia Scientific Advisory Boards. He serves on the Editorial Board of Movement Disorders, npj Parkinson's Disease, the Journal of Clinical Movement Disorders, Movement Disorders Clinical Practice and F1000 Research. He has a clinical and research interest in Parkinson’s disease and movement disorders.

Disclosures

Dr. Fung receives a salary from NSW Health, has received unrestricted research grants from the Michael J. Fox Foundation, Abbvie and Merz, is on Advisory Boards and/or has received travel grants from Abbvie, Allergan, Cavion, Ipsen, Merz, Praxis, Seqirus, Stada, Teva and UCB, and receives royalties from Health Press Ltd.